Toronto, Ontario, Canada-based Fight Against Cancer Innovation Trust (“FACIT”) has launched The Prospects Oncology Fund.
The evergreen fund, whose capital is allocated annually, is designed to advance early-stage cancer discoveries by supporting the proof-of-concept studies needed to attract seed-stage investment.
Managed by FACIT, the Prospects Fund aims to provide pre-seed, promising oncology discoveries in Ontario with up to $200K to help the technology reach a funding-ready inflection point. Applications for the Prospects Fund are accepted and awarded bi-annually.
Selected projects are provided with a development roadmap and the capital to execute key studies designed to improve commercial attractiveness. In addition, successful applicants are provided with guidance and access to FACIT’s network of experts.
Established by the Ontario Institute for Cancer Research (OICR) as a strategic partner to accelerate commercialization of oncology innovations, the Fight Against Cancer Innovation Trust (FACIT) helps bring these innovations from the lab to the marketplace to benefit patients, researchers, investors and the Ontario economy.
FinSMEs
22/03/2017